(ARVN) Arvinas - Performance -68% in 12m
ARVN performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-78.54%
#156 in Peer-Group
Rel. Strength
5.10%
#7284 in Stock-Universe
Total Return 12m
-67.98%
#174 in Peer-Group
Total Return 5y
-76.58%
#132 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 17.7 |
| High / Low | USD |
|---|---|
| 52 Week High | 32.73 USD |
| 52 Week Low | 6.07 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 90.89 |
| Buy/Sell Signal +-5 | 0.34 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ARVN (-68%) vs XLV (-4.6%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
3.27% | 140% | 332% | 64.3 | 57.8 | 0.61 | 23.7% | -5.15% |
| NVS NYSE Novartis |
4.24% | 16.8% | 78.4% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| LLY NYSE Eli Lilly |
1.94% | -14.1% | 396% | 63.3 | 35.6 | 1.19 | 58.2% | 18.9% |
| NOVN SW Novartis |
0.79% | 3.78% | 49.4% | 18.4 | 13.9 | 1.36 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-6.42% | 2.63% | 46.3% | 18.6 | 8.61 | 0.38 | -25.2% | 3.11% |
| SFZN SW Siegfried Holding |
-4.86% | -7.48% | 108% | 24.2 | 23.6 | 1.48 | -42.4% | -29.3% |
| AZN NASDAQ AstraZeneca |
-4.86% | -8.38% | 44% | 28.5 | 15.7 | 0.95 | 52.7% | 22.3% |
| IPN PA Ipsen |
-2.2% | -6.85% | 38.7% | 24.1 | 10.2 | 0.73 | -6.40% | -6.33% |
Performance Comparison: ARVN vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for ARVN
| Total Return (including Dividends) | ARVN | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 14.39% | 2.14% | 5.25% |
| 3 Months | 21.19% | 0.64% | 24.13% |
| 12 Months | -67.98% | -4.57% | 14.15% |
| 5 Years | -76.58% | 42.89% | 111.83% |
| Trend Score (consistency of price movement) | ARVN | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 38.1% | 35.8% | 81% |
| 3 Months | 15.8% | -28.5% | 96.9% |
| 12 Months | -89.9% | -74.5% | 44.9% |
| 5 Years | -63.4% | 87.9% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th85.00 | 11.99% | 8.69% |
| 3 Month | %th62.00 | 20.42% | -2.37% |
| 12 Month | %th13.50 | -66.45% | -71.95% |
| 5 Years | %th32.00 | -83.61% | -88.95% |
FAQs
Does Arvinas (ARVN) outperform the market?
No,
over the last 12 months ARVN made -67.98%, while its related Sector, the Health Care Sector SPDR (XLV) made -4.57%.
Over the last 3 months ARVN made 21.19%, while XLV made 0.64%.
Performance Comparison ARVN vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ARVN vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 3.7% | 9.1% | -65.7% | -82% |
| US NASDAQ 100 | QQQ | 4% | 9.1% | -66.4% | -81% |
| German DAX 40 | DAX | 5.9% | 15.8% | -77.9% | -97% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 3.9% | 11.2% | -69.2% | -88% |
| Hongkong Hang Seng | HSI | 4.1% | 8.3% | -85.2% | -107% |
| India NIFTY 50 | INDA | 5.6% | 10.9% | -66.1% | -67% |
| Brasil Bovespa | EWZ | 1.3% | 5.6% | -90.8% | -78% |
ARVN vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 5.1% | 8.5% | -69.9% | -92% |
| Consumer Discretionary | XLY | 4.2% | 11.2% | -58.1% | -86% |
| Consumer Staples | XLP | 3.4% | 13.8% | -67.4% | -77% |
| Energy | XLE | 3.4% | 7.3% | -61.6% | -68% |
| Financial | XLF | 3% | 9.3% | -70.7% | -98% |
| Health Care | XLV | 4.3% | 12.3% | -58.4% | -63% |
| Industrial | XLI | 3.7% | 10.2% | -73.6% | -93% |
| Materials | XLB | 1.5% | 10.1% | -70.3% | -74% |
| Real Estate | XLRE | 3.8% | 13.4% | -65.5% | -81% |
| Technology | XLK | 3% | 5.7% | -68.1% | -79% |
| Utilities | XLU | 4.8% | 12.6% | -69% | -91% |
| Aerospace & Defense | XAR | 5.9% | 7.3% | -84.3% | -117% |
| Biotech | XBI | 2.8% | 11% | -52.5% | -61% |
| Homebuilder | XHB | 1.2% | 7.4% | -58.6% | -74% |
| Retail | XRT | 1.2% | 9.4% | -61.4% | -79% |
ARVN vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 2.8% | 5.95% | -57.3% | -60% |
| Natural Gas | UNG | 13.2% | 24.2% | -48.9% | -66% |
| Gold | GLD | 3.5% | 15.6% | -86.4% | -107% |
| Silver | SLV | 2.7% | 7.5% | -83.1% | -86% |
| Copper | CPER | 4.7% | 9.8% | -82.8% | -79% |
ARVN vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 5.6% | 13.3% | -62.3% | -66% |
| iShares High Yield Corp. Bond | HYG | 4.9% | 12.8% | -64.6% | -78% |